Biotech Roundup: Kadmon Debt, Hemo Data, Loose Lips & More
Xconomy
JUNE 17, 2016
Data from a hematology conference stoked dreams of approval, though still on a far horizon, for a couple drug makers. Despite technical differences and the early nature of the data that made comparison difficult, Wall Street declared Spark this week’s winner. You think a Game 7 in the NBA Finals is going to be epic? .
55 
Let's personalize your content